Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease

被引：30

作者：

Silvestrini, Mauro ^{[1
]}

Viticchi, Giovanna ^{[1
]}

Altamura, Claudia ^{[2
]}

Luzzi, Simona ^{[1
]}

Balucani, Clotilde ^{[3
]}

Vernieri, Fabrizio ^{[2
]}

机构：

[1] Univ Politecn Marche, Neurol Clin, I-60020 Ancona, Italy

[2] Campus Biomed Univ, Neurol Clin, Rome, Italy

[3] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2012年 / 32卷 / 03期

关键词：

Alzheimer's disease; vascular markers; vascular risk factors; WHITE-MATTER LESIONS; MILD COGNITIVE IMPAIRMENT; INTIMA-MEDIA THICKNESS; CEREBRAL VASOMOTOR REACTIVITY; GLYCATION END-PRODUCTS; MIDLIFE BLOOD-PRESSURE; APOLIPOPROTEIN-E; CAROTID ATHEROSCLEROSIS; AMYLOID-BETA; ATRIAL-FIBRILLATION;

D O I：

10.3233/JAD-2012-121240

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Increasing evidence is emerging that vascular disease and its risk factors play a role in the development of Alzheimer's disease (AD) and affect the probability of an adverse outcome. The aims of this review are to explore the relationship between vascular risk factors and AD and to discuss the potential use of vascular markers in the clinical approach to cognitive impairment. Moreover, we present evidence about the potential use of ultrasonographic and neuroradiologic markers of cognitive impairment in order to establish possible treatment strategies in subjects with a clinical profile at risk of developing AD.

引用

页码：689 / 698

页数：10

共 50 条

[31] Modifiable Risk Factors for Alzheimer's Disease
Edwards, George A., III
Gamez, Nazaret
Escobedo, Gabriel, Jr.
Calderon, Olivia
Moreno-Gonzalez, Ines
FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
[32] Sex differences in risk factors, burden, and outcomes of cerebrovascular disease in Alzheimer's disease populations
Morrison, Cassandra
Dadar, Mahsa
Collins, Donald Louis
ALZHEIMERS & DEMENTIA, 2024, 20 (01) : 34 - 46
[33] Genes, pathways and risk prediction in Alzheimer's disease
Hardy, John
Escott-Price, Valentina
HUMAN MOLECULAR GENETICS, 2019, 28 (R2) : R235 - R240
[34] Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease
Yassi, Nawaf
Hilal, Saima
Xia, Ying
Lim, Yen Ying
Watson, Rosie
Kuijf, Hugo
Fowler, Christopher
Yates, Paul
Maruff, Paul
Martins, Ralph
Ames, David
Chen, Christopher
Rowe, Christopher C.
Villemagne, Victor L.
Salvado, Olivier
Desmond, Patricia M.
Masters, Colin L.
JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 897 - 907
[35] Physiological separation of Alzheimer's disease and Alzheimer's disease with significant levels of cerebrovascular symptomology and healthy controls
Lithgow, Brian J.
Dastgheib, Zeinab
Anssari, Neda
Mansouri, Behzad
Blakley, Brian
Ashiri, Mehrangiz
Moussavi, Zahra
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2021, 59 (7-8) : 1597 - 1610
[36] Is Alzheimer's disease a systemic disease?
Morris, Jill K.
Honea, Robyn A.
Vidoni, Eric D.
Swerdlow, Russell H.
Burns, Jeffrey M.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (09): : 1340 - 1349
[37] Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
Ramos-Cejudo, Jaime
Wisniewski, Thomas
Marmar, Charles
Zetterberg, Henrik
Blennow, Kaj
de Leon, Mony J.
Fossati, Silvia
EBIOMEDICINE, 2018, 28 : 21 - 30
[38] Cerebrovascular risk factors in Alzheimer's disease:: Brain hemodynamics and pharmacogenomic implications
Cacabelos, R
Fernández-Novoa, L
Lombardi, V
Corzo, L
Pichel, V
Kubota, Y
NEUROLOGICAL RESEARCH, 2003, 25 (06) : 567 - 580
[39] APOE and Alzheimer's Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
Brandon, Jason A.
Farmer, Brandon C.
Williams, Holden C.
Johnson, Lance A.
FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
[40] Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease
Asby, Daniel
Boche, Delphine
Allan, Stuart
Love, Seth
Miners, J. Scott
BRAIN, 2021, 144 : 1869 - 1883

← 1 2 3 4 5 →